TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | -97.0% | 97 | -98.9% | 0.00% | – |
| Q1 2022 | $230,000 | -36.8% | 8,546 | +11.6% | 0.00% | – |
| Q4 2021 | $364,000 | -28.8% | 7,658 | -0.4% | 0.00% | – |
| Q3 2021 | $511,000 | -14.0% | 7,686 | +1.1% | 0.00% | -100.0% |
| Q2 2021 | $594,000 | +22.7% | 7,602 | +48.5% | 0.00% | – |
| Q1 2021 | $484,000 | -14.8% | 5,120 | +9.9% | 0.00% | -100.0% |
| Q4 2020 | $568,000 | +61.4% | 4,660 | +15.3% | 0.00% | – |
| Q3 2020 | $352,000 | +70.9% | 4,040 | +27.0% | 0.00% | – |
| Q2 2020 | $206,000 | +80.7% | 3,180 | +25.2% | 0.00% | – |
| Q1 2020 | $114,000 | – | 2,540 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |